BIT 4.55% 2.1¢ biotron limited

Ann: BIT225 Phase 2 HIV-1 Clinical Trial Fully Recruited, page-27

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,649 Posts.
    lightbulb Created with Sketch. 550
    Fair enough and thanks for answering my question. I appreciate your honesty. With regard to your comment "One would suspect we would be partnered going into a phase 3 trial", I think there is one thing everybody can bank on. Without a partner there will be no phase 3 trial. Biotron can't go it alone. What do you think the backup plan is in case BIT-010 and BIT-011 don't convince BP do throw in cash?

    They were very confident of a partner after BIT-009 also. Lets hope history doesn't repeat and the 2023 trial results bring the long awaited bonanza for investors, not just quick profit for traders like happened last time. Personally I believe its the long term faithful who deserve to see a profit more than anybody. The traders will make money on speculating either way.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.